Showing results (151-160 of 167) with videos related to
Sort By:
Pageof 17
Global Food Security|September 13, 2021
Emerging COVID-19 impacts, responses, and lessons for building resilience in the seafood systemDavid C Love, Edward H Allison, Frank Asche, et al.Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.Bioorganic & Medicinal Chemistry Letters|January 13, 2006
Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluationQun Li, Tongmei Li, Gui-Dong Zhu, et al.Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.Journal of Medicinal Chemistry|April 2, 2019
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) StabilizerAndrew M Petros, Alla Korepanova, Clarissa G Jakob, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2006
Isoquinoline-pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activityGui-Dong Zhu, Jianchun Gong, Akiyo Claiborne, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Synthesis and structure-activity relationship of 3,4'-bispyridinylethylenes: discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancerQun Li, Keith W Woods, Sheela Thomas, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.Journal of Medicinal Chemistry|June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitorsClarence J Maring, Vincent S Stoll, Chen Zhao, et al.Scientific Reports|August 26, 2022
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal siteEric R Goedken, Maria A Argiriadi, Justin D Dietrich, et al.Pageof 17